Trademarkia Logo

Canada

C$
GEOMETRIC DESIGN
REGISTERED

on 26 Jul 2023

Last Applicant/ Owned by

Iovance Biotherapeutics, Inc.

825 Industrial Road, Suite 400San Carlos CA 94070

US

Serial Number

2088879 filed on 9th Nov 2020

Registration Number

TMA1191590 registered on 26th Jul 2023

Registration expiry Date

9th Nov 2030

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

GEOMETRIC DESIGN

Trademark usage description

pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; diagnostic Read More

Vienna Information


26 . 2 . 3

Sectors of circles or ellipses (except 26.2.7)Secteurs de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

29 . 1 . 5

VioletViolet

29 . 1 . 2

Yellow, goldJaune, or

29 . 1 . 7

BrownBrun

Classification Information


Class [005]
Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; diagnostic preparations for medical use, namely, biological diagnostic preparations for diagnosing cancer; diagnostic preparations for medical use, namely, biological diagnostic preparations for medical diagnosis in the fields of cancer, oncology, and immune system diseases and disorders.


Classification kind code

11

Class [044]
Medical treatment of cancer via the modification of cells; medical services, namely, medical services for the treatment of a wide range of diseases and medical conditions, namely cancer, oncological diseases and disorders, and immune system diseases and disorders via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical services, namely, medical services for the diagnosis and treatment of a wide range of diseases and medical conditions, namely cancer, oncological diseases and disorders, and immune system diseases and disorders; providing medical information relating to oncology and immunotherapy treatment; providing medical information relating to diagnosis and treatment for cancer, oncological diseases and disorders, and immune system diseases and disorders, and relating to immunotherapy treatments, tumor infiltrating lymphocyte (TIL) therapies, T-cell-based immunotherapy and peripheral blood lymphocyte (PBL) therapies; providing pharmaceutical information; providing medical information in the field of isolation, collection, and banking of human biological tissue for immunotherapy; medical consultations relating to diagnosis and treatment for cancer, oncological diseases and disorders, and immune system diseases and disorders; medical consultations relating to immunotherapy treatments, tumor infiltrating lymphocyte (TIL) therapies, T-cell-based immunotherapy and peripheral blood lymphocyte (PBL) therapies; pharmaceutical consultancy services; medical consultation services in the field of isolation, collection, and banking of human biological tissue for immunotherapy; isolation, collection, and banking of human biological tissue for immunotherapy.


Classification kind code

11

Mark Details


Serial Number

2088879

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 18th Jul 2022
Agent Changed
Submitted for opposition 22
on 8th Jul 2022
Search Recorded
Submitted for opposition 20
on 8th Jul 2022
Examiner's First Report
Submitted for opposition 223
on 8th Jul 2022
Total Provisional Refusal
Submitted for opposition 256
on 4th Jan 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 4th Mar 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 3rd Mar 2021
Formalized
Submitted for opposition 1
on 3rd Mar 2021
Created
Submitted for opposition 228
on 9th Nov 2020
International Registration
Submitted for opposition 30
on 9th Nov 2020
Filed